Genetic deficiency or pharmacological inhibition of cyclooxygenase‐1 or ‐2 induces mouse keratinocyte differentiation in vitro and in vivo

This publication has 32 references indexed in Scilit:

• Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis
  Carcinogenesis: Integrative Cancer Research, 2002
• Why there are two cyclooxygenase isozymes
  Journal of Clinical Investigation, 2001
• Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin
  Proceedings of the National Academy of Sciences, 2001
• Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition
  Carcinogenesis: Integrative Cancer Research, 1999
• A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells
  Japanese Journal of Cancer Research, 1999
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
  Molecular Carcinogenesis, 1999
• Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2
  Molecular Carcinogenesis, 1998
• Localization of Prostaglandin-H Synthase-1 and -2 in Mouse Skin: Implications for Cutaneous Function
  Experimental Cell Research, 1998
• Prostaglandin Endoperoxide H Synthases-1 and -2
  Published by Elsevier ,1996
• Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro
  Biochemical Journal, 1995